Our Team: New Ventures and Business Development
Sam Kiderman, PhD Director, New Ventures
Sam's main focus is development, finance and growth of new spin-offs. Prior to joining CCI, he was responsible for Clinic Care, an arm of the Cleveland Clinic, which provides multifunctional support for the Clinic and subsidiaries. Sam has extensive experience in business development and has been involved in ... Continue Reading
Jackie Gerberry, CPA, MBA, Senior Project Manager
Jackie specializes in the governance of Innovations Portfolio Companies to ensure that they are operating in a fashion that optimizes the potential clinical and financial return to Cleveland Clinic and minimizes risk to the Clinic. Previously, she was Vice President in the Healthcare Investment Banking Group... Continue Reading
Bill Kolosi New Ventures Development Officer
Bill's role is a liaison between the Clinic and corporate partners, managing the development of new medical devices. A mechanical engineer, he spent eleven years as a consultant developing medical device prototypes for early-stage startups in both the San Francisco Bay Area and northeast Ohio. He's listed on five patents... Continue Reading
Jeffrey Marshall, PhD Senior New Ventures Officer
Jeff specializes in technology selection in the context of creation, development and growth of new ventures. Leveraging extensive transactional experience in the capital markets, Jeff also focuses on capitalization and financing strategies for CCI spin-offs... Continue Reading
Joseph Rich, JD, MBA New Ventures Officer
Joe's primary responsibilities include the development and growth of Cleveland Clinic new ventures. He manages projects that are potential spin-off companies and assists existing spin-offs with fundraising, marketing, growth and development. He serves on the board of directors for FlexLife Health. In addition, Joe assists with managing... Continue Reading
David Wang Senior Innovations Officer
Prior to joining Cleveland Clinic, David established his own medical device company, secured $3 million venture funding to develop innovative orthopedic implants, and led the company to complete new product development... Continue Reading